glp 1 canker sores Medscape | After all the headlines about “Ozempic mouth” — and “Ozempic breath” and “Ozempic teeth” — emerging research points to possible Have you ever had a

Retatrutide has no MHRA marketing authorisation and is only legally available within authorised clinical trials in the UK

Its daily uses gradually stops hyperpigmentation problems such as freckles, acne, scars, liver spots , pigment marks or stretch mark that may occur from pregnancy or use of other bleaching cream

Close behind it on the regulatory timeline is CagriSema, a once-weekly combination of the GLP-1 agonist semaglutide and the amylin analog cagrilintide, which finished its pivotal program with around 20 percent weight loss and sits under FDA review

Athletes with pre-existing metabolic issues (like insulin resistance) should exercise extra caution